Latest research
Every new paper in 280 characters, with how strong the evidence is and what readers question about it. Free to read.
Top papers this month · This week's roundup
Trending topics
Systematic review of 13 observational studies (47 million people): migraine was associated with higher adjusted risk of retinal vascular events (RR 2.04), retinal artery occlusion (RR 2.12) and retinal vein occlusion (RR 1.72) vs no migraine. Maculopathy evidence was unclear.
Meta-analysisn = 47,042,175
Mohamed et al. Migraine as a risk factor for retinal vascular events and maculopathies: a systematic review and meta-analysis of 47 million individualsMeta-analysis of 14 cohort studies (25 cohorts; 36,338,318 participants) found a bidirectional association between mood disorders and autoimmune diseases of the nervous system (RR 2.41), with very high heterogeneity (I² 98.8%).
Meta-analysisn = 36,338,318
Wang et al. Association between mood disorders and autoimmune diseases of the nervous system: A systematic review and meta-analysis of cohort studiesMeta-analysis of cohort studies (5,904,415 participants): lower neighbourhood socioeconomic status was associated with higher lung cancer incidence (pooled estimate 1.33; low certainty) and mortality (1.17; moderate certainty), with high heterogeneity.
Meta-analysisn = 5,904,415
Jalili et al. The association between neighborhood socioeconomic status and lung cancer incidence and mortality risk: A systematic review and meta-analysis of cohort studies from North America, Europe, and AsiaComponent network meta-analysis of 237 RCTs (4.36 million participants) on raising vaccine uptake: effective components varied by age; for adults, human interaction, extended opportunities, scheduling help, cost payments and motivational interviewing were effective.
Meta-analysisn = 4,361,717
Davies et al. Effectiveness of interventions to increase vaccine uptake: component network meta-analysisSystematic review of 116 studies (53,770 participants) from 29 African countries: pooled maternal rectovaginal GBS colonisation was 18% and vertical transmission 47%; serotypes V, Ia and III predominated; resistance high to tetracycline (87%), low to penicillin (9%).
Meta-analysisn = 53,770
Melaku et al. Group B Streptococcus in African pregnancies: A systematic review and meta-analysis of its maternal rectovaginal colonization, vertical transmission, serotype distribution, and antimicrobial resistanceSystematic review of 21 observational studies (22,968 patients with rheumatoid arthritis): difficult-to-treat disease was associated with smoking history (OR 1.16), obesity (1.38), fibromyalgia (2.20) and depression (1.74), but not current smoking or anxiety.
Meta-analysisn = 22,968 patients
Xie et al. Associated lifestyle factors and comorbidities of difficult-to-treat rheumatoid arthritis: a systematic review and meta-analysisMeta-analysis of 6 placebo-controlled RCTs (18,011 pregnant women; 17,769 infants): maternal RSV vaccination reduced severe infant RSV lower respiratory tract infection (RR 0.35) and hospitalisation (RR 0.53) within 180 days; no safety signal for preterm birth (RR 1.15).
Meta-analysisn = 18,011 pregnant women
Lopes et al. The impact of maternal respiratory syncytial virus vaccination on infant and perinatal outcomes: a systematic review and meta-analysis of randomized controlled trialsSystematic review of 30 studies (13,902 patients with psoriasis) with meta-analysis: older age, higher BMI, comorbidities and special-site involvement were associated with lower odds of clearance on biologics; family history with higher odds.
Meta-analysisn = 13,902
Mao et al. Predictors of clinical response to biologics in psoriasis: A systematic review and meta-analysisSystematic review of 10 studies (13,224 adolescents): two to four non-suicidal self-injury trajectories were found, with a pooled 22.9% on a medium-to-high-risk trajectory; predictors included emotional dysregulation, depression and family conflict.
Meta-analysisn = 13,224
You et al. Longitudinal trajectories of non-suicidal self-injury in adolescents and their predictors: A systematic review and meta-analysisIn 12,327 patients with noncardioembolic ischaemic stroke or high-risk TIA on antiplatelet therapy, asundexian 50 mg daily cut ischaemic stroke vs placebo (6.2% vs 8.4%; HR 0.74) without more major bleeding (1.9% vs 1.7%).
RCTn = 12,327
Sharma et al. Asundexian for Secondary Stroke Prevention